Genworth Holdings, Inc. sold $34.0M of ACT
Genworth Holdings, Inc. sold 687,379 shares of Enact Holdings, Inc. (ACT) at $49.40 ($33.95M total) on 2026-08-31.
Enact Holdings, Inc.
No enriched coverage for $ACT in the last 7 days.
Genworth Holdings, Inc. sold 687,379 shares of Enact Holdings, Inc. (ACT) at $49.40 ($33.95M total) on 2026-08-31.
Stolove Evan (EVP, Gen. Counsel & Secretary) sold 20,024 shares of Enact Holdings, Inc. (ACT) at $49.52 ($0.99M total) on 2026-08-17.
Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.
Recent ACT coverage spans insider activity and earnings.
In the last 30 days, ACT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($34.0M). The most active reporter was Genworth Holdings, Inc. with 1 filing.
Large insider sale may signal reduced confidence, potentially pressuring ACT stock lower.
Insider sale may signal reduced confidence, potentially pressuring the stock short-term.
Guidance uplift plus capital return range revision is the primary near-term catalyst, partially offset by management warning of rising delinquencies in 2H26.
Results appear broadly in-line on revenue with a modest EPS beat, suggesting limited upside surprise versus expectations.
Quarterly earnings, capital return guidance, and dividend declaration create a near-term catalyst for ACT’s valuation and capital-return expectations.
AlphAI scores every news story that mentions ACT with an AI model for sentiment and relevance, and aggregates insider trades from Enact Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Genworth Holdings, Inc. sold 687,379 shares of Enact Holdings, Inc. (ACT) at $49.40 ($33.95M total) on 2026-08-31.
1 min readStolove Evan (EVP, Gen. Counsel & Secretary) sold 20,024 shares of Enact Holdings, Inc. (ACT) at $49.52 ($0.99M total) on 2026-08-17.
1 min readEnact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.
9 min readEnact Holdings (NASDAQ: ACT) reported Q2 CY2026 results. Revenue rose 1.6% year on year to $317.3 million and matched Wall Street expectations, according to the article. Non-GAAP profit was $1.26 per share, 6.1% above analysts’ consensus. The stock was flat at $47.82 after the release.
3 min readEnact Holdings, Inc. (ACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ENACT REPORTS SECOND QUARTER 2026 RESULTS; ANNOUNCES $0.24 QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $175 million, or $1.25 per diluted share Adjusted Operating Income of $177 million, or $1.26 per diluted share Return on Equity of
6 min readEnact Holdings (ACT) will report Q2 earnings Wednesday after the bell. The company previously reported $317.9 million revenue, up 2.5% year on year, with a narrow EPS beat. For the upcoming quarter, analysts expect revenue to rise 1.3% year on year. The article cites an average analyst price target of $46 versus $47.91.
2 min readGenworth Holdings, Inc. sold 523,226 shares of Enact Holdings, Inc. (ACT) at $45.92 ($24.03M total) on 2026-07-31.
2 min readGenworth Holdings, Inc. sold 605,067 shares of Enact Holdings, Inc. (ACT) at $42.28 ($25.58M total) on 2026-06-30.
3 min readGould Brian (EVP & Chief Operations Officer) sold 23,000 shares of Enact Holdings, Inc. (ACT) at $41.18 ($0.95M total) on 2026-06-01.
1 min readGenworth Holdings, Inc. sold 602,440 shares of Enact Holdings, Inc. (ACT) at $42.91 ($25.85M total) on 2026-05-29.
3 min read